CompanyTrack
E

EXSCIENTIA LIMITED

Active London

Activities of other holding companies n.e.c.

501 employees Website
Life sciences and medical technology Activities of other holding companies n.e.c.Other research and experimental development on natural sciences and engineering
E

EXSCIENTIA LIMITED

Activities of other holding companies n.e.c.

Founded 29 Jun 2021 Active London, England 501 employees exscientia.ai
Life sciences and medical technology Activities of other holding companies n.e.c.Other research and experimental development on natural sciences and engineering
Accounts Submitted 12 Nov 2025
Confirmation Statement Submitted 17 Nov 2025
Net assets £355.73M £123.15M 2023 year on year
Total assets £510.72M £138.92M 2023 year on year
Total Liabilities £155.00M £15.77M 2023 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

4th Floor South 3 Pancras Square King’S Cross London N1C 4AG England

Office (Cambridge)

The Bradfield Centre, 184 Cambridge Science Park Rd, Milton, Cambridge CB4 0GA

Office (Oxford Science Park, Oxford)

The Schrödinger Building, OX4 4GE

Credit Report

Discover EXSCIENTIA LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2019–2023)

Cash in Bank

£259.46M

Decreased by £145.11M (-36%)

Net Assets

£355.73M

Decreased by £123.15M (-26%)

Total Liabilities

£155.00M

Decreased by £15.77M (-9%)

Turnover

£21.33M

Decreased by £7.71M (-27%)

Employees

501

Increased by 95 (+23%)

Debt Ratio

30%

Increased by 4 (+15%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 109,014,445 Shares £23627173497.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Aug 2021108,690,325£23627173497.21m£217.38m
26 Aug 20218,726£0£0
10 Aug 202177,699£155k£2
10 Aug 20214,848£10k£2
10 Aug 202130,255£61k£2

Officers

Officers

4 active 9 resigned
Status
Ben Roberts TaylorDirectorAmericanUnited Kingdom4810 Aug 2021Active
Christopher GibsonDirectorAmericanUnited States4220 Nov 2024Active
Nathan Ben HatfieldDirectorAmericanUnited States4520 Nov 2024Active
Nathan HatfieldSecretaryUnknownUnknown20 Nov 2024Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Recursion Pharmaceuticals, Inc.

United States Of America

Active
Notified 20 Nov 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Andrew Lee Hopkins

Ceased 10 Aug 2021

Ceased

Group Structure

Group Structure

RECURSION PHARMACEUTICALS, INC. united states of america
EXSCIENTIA LIMITED Current Company
EXSCIENTIA (UK) HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
17 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-17 with no updatesView(3 pages)
12 Nov 2025AccountsAnnual accounts made up to 2024-12-31View(24 pages)
1 Sept 2025AddressChange Registered Office Address Company With Date Old Address New AddressView(1 page)
14 Jul 2025Persons With Significant ControlRecursion Pharmaceuticals, Inc. notified as a person with significant controlView(2 pages)
30 May 2025Confirmation StatementSecond Filing Of Confirmation Statement With Made Up DateView(4 pages)
17 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-17 with no updates

12 Nov 2025 Accounts

Annual accounts made up to 2024-12-31

1 Sept 2025 Address

Change Registered Office Address Company With Date Old Address New Address

14 Jul 2025 Persons With Significant Control

Recursion Pharmaceuticals, Inc. notified as a person with significant control

30 May 2025 Confirmation Statement

Second Filing Of Confirmation Statement With Made Up Date

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-17 with no updates

2 months ago on 17 Nov 2025

Annual accounts made up to 2024-12-31

2 months ago on 12 Nov 2025

Change Registered Office Address Company With Date Old Address New Address

4 months ago on 1 Sept 2025

Recursion Pharmaceuticals, Inc. notified as a person with significant control

6 months ago on 14 Jul 2025

Second Filing Of Confirmation Statement With Made Up Date

7 months ago on 30 May 2025